Nasdaq

Haemonetics' (HAE) New TEG 6s Cartridge Gets FDA Approval

Haemonetics Corporation HAE announced receipt of the FDA 510(k) clearance for the TEG 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge. This new cartridge expands Haemonetics' TEG 6s ...
Business Insider

Recommendation for TEG Testing in COVID-19 Patients will Ensure Bright Opportunities for the Point-Of-Care Coagulation Testing Devices Market, Opines TMR

ALBANY, N.Y., April 20, 2021 /PRNewswire/ -- The increase in the number of bleeding disorders across the globe has been alarming in recent years. A change in lifestyle habits and other factors have ...
National Institute for Health and Care Excellence

Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems)

The diagnostics advisory committee reviewed the evidence available on the cost effectiveness of viscoelastometric testing to help detect, manage and monitor haemostasis in cardiac surgery and in the ...
KTLA

Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge

BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, ...
National Institute for Health and Care Excellence

Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems)

The National Institute for Health and Care Excellence (NICE) is producing guidance on using viscoelastometric point-of-care testing (ROTEM, TEG and Sonoclot systems) in the NHS in England. The ...